Royalty Pharma plc RPRX
70.01 USD +0.56 (+0.81%)
At closeNov 12, 2026, 5:12 AM EST
70.20 +0.19 +0.27%
Pre-market · Nov 12, 5:12 AM ET
68.88 Day range 70.27
37.31 52-week range 70.27
- YTD
- +81.19%
- 1 year
- +76.84%
News
247wallst.com 3 Biotech Stocks That Actually Pay Dividends and Keep Raising Them Biotech usually torches cash and dilutes shareholders to fund the next trial. Three drugmakers flip that script, and the one with the smallest yield may be hiding the sturdiest payout of all.
fool.com Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug Revolution Medicines' daraxonrasib has received FDA approval. Royalty Pharma estimates that the drug could produce peak revenues of $11 billion.
zacks.com Royalty Pharma (RPRX) Upgraded to Buy: What Does It Mean for the Stock? Royalty Pharma (RPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
benzinga.com Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $78 Citigroup analyst Geoff Meacham maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and raises the price target from $70 to $78.
benzinga.com Royalty Pharma Q3 Adj. EPS $1.21 Beats $1.18 Estimate, Sales $690.000M Miss $796.528M Estimate Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.18 by 2.54 percent. This is a 3.42 percent increase over earnings of $1.17…
benzinga.com Here's How Much $100 Invested In Royalty Pharma 10 Years Ago Would Be Worth Today Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 32.09% on an annualized basis producing an average annual return of 45.51%. Currently, Royalty Pharma has a market…
benzinga.com ARM, McDonald's On Deck Wednesday As AI Demand, Consumer Spending Face Test ARM Holdings headlines Wednesday’s reports, with investors looking for evidence that AI-related demand can support the chip designer after a sharp stock pullback. McDonald’s, Novo Nordisk, Uber…
benzinga.com If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 15 years by 6.82% on an annualized basis producing an average annual return of 19.77%. Currently, Royalty Pharma has a market…